Melanocyte Transplant for Vitiligo: Who Is a Candidate?
Surgical melanocyte transplantation offers something medical treatments cannot: direct placement of new melanocytes into depigmented skin, bypassing the need for a surviving follicular reservoir. For patients with stable vitiligo who have not achieved satisfactory results from phototherapy or topicals — particularly those with leukotrichia indicating depleted follicular reserves — surgical transplantation may be the most realistic path to meaningful repigmentation.
What is melanocyte transplantation?
The core principle: take pigment-producing melanocytes from normally pigmented donor skin, and transplant them into depigmented recipient skin. If the transplant is successful, the transplanted melanocytes take up residence in the recipient area and begin producing pigment.
Several techniques exist, differing in how donor cells are collected and delivered:
MKTP (melanocyte-keratinocyte transplant procedure)
The most commonly used modern technique. Donor skin (usually taken from the thigh or buttock) is processed in a specialised laboratory to produce a suspension of melanocytes and keratinocytes. The recipient site (vitiligo patch) is prepared by superficial dermabrasion, and the cell suspension is applied over the prepared area and covered with dressings.
MKTP can treat relatively large areas (up to 100cm² or more in a single session) because the donor cells are expanded and distributed in suspension rather than transplanted as intact tissue. It is performed in specialised dermatology centres.
Suction blister epidermal grafting (SBEG)
A thin-bladed technique where suction is applied to donor skin, creating a blister filled with epidermal cells including melanocytes. The blister roof (a thin epidermal sheet containing melanocytes) is transferred to a prepared recipient site.
Simpler and less equipment-intensive than MKTP, making it available in more centres. Treats smaller areas per session due to the blister size limitation. Suitable for limited, focal patches.
Split-thickness skin grafting
A section of thin donor skin is grafted directly to the recipient site. More invasive than SBEG or MKTP, with donor site scarring. Rarely used for vitiligo specifically; more commonly used in the context of burns or wound coverage.
Punch minigrafting
Small circular punches of normal skin are implanted into holes created in the vitiligo patch. An older technique, increasingly replaced by MKTP and SBEG, which give better cosmetic outcomes. Still used in some settings.
Who is a suitable candidate?
Stable vitiligo is the primary requirement. Stability is defined as:
- No new patches for at least six months to one year (many centres require 12 months)
- No enlargement of existing patches in the stability period
- A stable minitest graft (a small test graft placed ahead of a full procedure) showing colour retention without spread
Transplanting into active vitiligo does not work well — the ongoing autoimmune attack will destroy the transplanted melanocytes before they can establish.
Limited response to medical treatment: Surgical transplantation is typically considered after adequate trials of phototherapy and topicals have not produced satisfactory repigmentation. It complements medical treatment rather than replacing it.
Areas with depleted follicular reserves: Patients with leukotrichia (white hair in patches), extensive acral vitiligo (hands, feet), or longstanding patches with exhausted melanocyte reservoirs are the patients who benefit most from surgical transplantation — because these are exactly the patients who cannot repigment through follicle-stimulating medical treatments.
Reasonable skin type match between donor and recipient: The donor site must have normal pigmentation matching the target shade. For patients with extensive vitiligo (>50% involvement), finding adequately pigmented donor skin may be difficult.
What results look like
MKTP results in patients who meet the stability criteria are among the most striking in vitiligo treatment. Published case series and small trials report:
- Greater than 80% repigmentation in 60–70% of suitable patients with facial and truncal vitiligo
- Results in segmental vitiligo are particularly strong — the bilateral symmetry of segmental disease means stable patches are common and the grafted melanocytes are not subject to ongoing immune attack
- Colour matching is often excellent — transplanted melanocytes produce pigment matching the patient’s natural skin tone
Results are weaker for acral sites (hands, feet, soles) — even with new melanocytes in place, these areas present challenges for melanocyte survival and function.
The minitest graft
Before committing to full-area surgical treatment, most centres perform a minitest graft — transplanting a small (1cm²) area and observing over three to four months. If the test graft holds and produces repigmentation without new vitiligo spreading around it, the patient is considered a good surgical candidate. If the test graft fails, surgery is postponed and the underlying activity is investigated.
Centres and availability
Melanocyte transplantation is not universally available — it requires specialised equipment, trained surgical staff, and in some cases a cell culture laboratory. Major academic medical centres and specialist vitiligo clinics perform these procedures. Finding a centre that performs MKTP specifically (rather than older punch grafting techniques) is worthwhile.
Cost
Surgical melanocyte transplantation is generally not covered by insurance as a cosmetic procedure in most countries. Costs vary widely by centre and procedure size — expect $2000–8000+ for a full-area MKTP session in the US. Some NHS centres in the UK offer SBEG under specific criteria.
After surgery
Post-procedural care includes dressing changes, avoiding sun exposure to the treated area, and continuing topical treatment to support the transplanted melanocytes. Concurrent phototherapy is sometimes added after the transplant has established to stimulate further expansion of the transplanted melanocytes.
The vitiligo treatment options comparison provides context on how surgical approaches fit within the full treatment landscape, and the how to track vitiligo progress guide covers documentation useful for establishing the stability criteria required for surgical candidacy.
